Nicholas Erho

Alıntı yapanlar

	Hepsi	2019 yılından bugüne
Alıntılar	8059	5306
h-endeksi	43	35
i10-endeksi	66	63

1300

650

325

975

20132014201520162017201820192020202120222023202438 117 257 518 773 970 1007 1060 1229 984 774 250

Genel erişim

Tümünü görüntüle

56 makale

2 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Elai DavicioniVeracyteveracyte.com üzerinde doğrulanmış e-posta adresine sahip
Mohammed AlshalalfaBioinformatician and Genomic Analystucalgary.ca üzerinde doğrulanmış e-posta adresine sahip
Edward M Schaeffer, MD PhDNorthwestern Universitynorthwestern.edu üzerinde doğrulanmış e-posta adresine sahip
Eric A. KleinChairman, Glickman Urological and Kidney Institute, Cleveland Clinicccf.org üzerinde doğrulanmış e-posta adresine sahip
Anirban P. Mitra, M.D., Ph.D.Assistant Professor, Departments of Urology and Computational Biomedicine, Cedars-Sinai Medicalcshs.org üzerinde doğrulanmış e-posta adresine sahip
Hussam AshabData scientistalumni.duke.edu üzerinde doğrulanmış e-posta adresine sahip
Matthew CooperbergUniversity of California, San Franciscoucsf.edu üzerinde doğrulanmış e-posta adresine sahip
Anamaria CrisanLead Research Scientist @ Tableau Researchtableau.com üzerinde doğrulanmış e-posta adresine sahip
Paul L NguyenProfessor of Radiation Oncology, Dana-Farber/Brigham and Women's, Harvard Medical SchoolLROC.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Scott TomlinsAssociate Professor of Pathology and Urologyumich.edu üzerinde doğrulanmış e-posta adresine sahip
Daniel SprattUniversity Hospitals Seidman Cancer Center/CWRUuhhospitals.org üzerinde doğrulanmış e-posta adresine sahip
Darby JS ThompsonBiostatistician, EMMES Canadaemmes.com üzerinde doğrulanmış e-posta adresine sahip
Tamara LotanProfessor and Deputy Director for Research, Department of Pathology, Johns Hopkins Universityjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Matthew SchipperProfessor of Radiation Oncology and Biostatistics, University of Michiganumich.edu üzerinde doğrulanmış e-posta adresine sahip
John PrensnerAssistant Professor, University of Michigan Medical Schoolumich.edu üzerinde doğrulanmış e-posta adresine sahip
Siamak DaneshmandProfessor of Urology (Clinical Scholar)med.usc.edu üzerinde doğrulanmış e-posta adresine sahip
Eila SkinnerProfessor of Urology, Stanford Universitystanford.edu üzerinde doğrulanmış e-posta adresine sahip
Luigi MarchionniAssociate Professor of Pathology and Laboratory Medicine, Weill Cornell Medicinemed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
Anirban SahuUniversity of Michiganumich.edu üzerinde doğrulanmış e-posta adresine sahip
Ewan A GibbIndependent Researcher

Takip et

Nicholas Erho

Research Science Manager, Amazon Alexa

amazon.com üzerinde doğrulanmış e-posta adresine sahip

machine learning datamining statistics transcriptome gene expression


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ... European urology 72 (4), 544-554, 2017	751	2017
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex JR Prensner, MK Iyer, A Sahu, IA Asangani, Q Cao, L Patel, IA Vergara, ... Nature genetics 45 (11), 1392-1398, 2013	716	2013
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy N Erho, A Crisan, IA Vergara, AP Mitra, M Ghadessi, C Buerki, ... PloS one 8 (6), e66855, 2013	650	2013
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer D Chakravarty, A Sboner, SS Nair, E Giannopoulou, R Li, S Hennig, ... Nature communications 5 (1), 5383, 2014	591	2014
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ... The lancet oncology 15 (13), 1521-1532, 2014	376	2014
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population RJ Karnes, EJ Bergstralh, E Davicioni, M Ghadessi, C Buerki, AP Mitra, ... The Journal of urology 190 (6), 2047-2053, 2013	357	2013
Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ... JAMA oncology 3 (12), 1663-1672, 2017	263	2017
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1 JR Prensner, S Zhao, N Erho, M Schipper, MK Iyer, SM Dhanasekaran, ... The lancet oncology 15 (13), 1469-1480, 2014	258	2014
Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediate-and high-risk men AE Ross, MH Johnson, K Yousefi, E Davicioni, GJ Netto, L Marchionni, ... European urology 69 (1), 157-165, 2016	256	2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ... The lancet oncology 17 (11), 1612-1620, 2016	212	2016
Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome S You, BS Knudsen, N Erho, M Alshalalfa, M Takhar, H Al-deen Ashab, ... Cancer research 76 (17), 4948-4958, 2016	176	2016
The immune landscape of prostate cancer and nomination of PD-L2 as a potential therapeutic target SG Zhao, J Lehrer, SL Chang, R Das, N Erho, Y Liu, M Sjöström, RB Den, ... JNCI: Journal of the National Cancer Institute 111 (3), 301-310, 2019	163	2019
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes SA Tomlins, M Alshalalfa, E Davicioni, N Erho, K Yousefi, S Zhao, ... European urology 68 (4), 555-567, 2015	153	2015
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy AE Ross, FY Feng, M Ghadessi, N Erho, A Crisan, C Buerki, D Sundi, ... Prostate cancer and prostatic diseases 17 (1), 64-69, 2014	152	2014
High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program DP Labbé, G Zadra, M Yang, JM Reyes, CY Lin, S Cacciatore, EM Ebot, ... Nature communications 10 (1), 4358, 2019	140	2019
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis B Benzon, SG Zhao, MC Haffner, M Takhar, N Erho, K Yousefi, P Hurley, ... Prostate cancer and prostatic diseases 20 (1), 28-35, 2017	138	2017
Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer L Yang, D Roberts, M Takhar, N Erho, BAS Bibby, N Thiruthaneeswaran, ... EBioMedicine 31, 182-189, 2018	137	2018
Prostate cancer radiomics and the promise of radiogenomics R Stoyanova, M Takhar, Y Tschudi, JC Ford, G Solórzano, N Erho, ... Translational cancer research 5 (4), 432, 2016	135	2016
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer A Urbanucci, SJ Barfeld, V Kytölä, HM Itkonen, IM Coleman, D Vodák, ... Cell reports 19 (10), 2045-2059, 2017	124	2017
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies R Stoyanova, A Pollack, M Takhar, C Lynne, N Parra, LLC Lam, ... Oncotarget 7 (33), 53362, 2016	113	2016

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar